204 related articles for article (PubMed ID: 26178213)
1. [Significance of P504s in distinction between solid pseudopapillary tumor of pancreas and pancreatic neuroendocrine tumors].
Chen Z; Shi H; Ying L; Zhai X; Fu X; Liu Q; Lou S
Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):320-2. PubMed ID: 26178213
[TBL] [Abstract][Full Text] [Related]
2. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.
Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S
Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097
[TBL] [Abstract][Full Text] [Related]
3. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
[TBL] [Abstract][Full Text] [Related]
5. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas.
Serra S; Salahshor S; Fagih M; Niakosari F; Radhi JM; Chetty R
JOP; 2007 May; 8(3):296-303. PubMed ID: 17495358
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis.
Ohara Y; Oda T; Hashimoto S; Akashi Y; Miyamoto R; Enomoto T; Satomi K; Morishita Y; Ohkohchi N
World J Gastroenterol; 2016 Oct; 22(38):8596-8604. PubMed ID: 27784972
[TBL] [Abstract][Full Text] [Related]
7. Solid pseudopapillary neoplasms of the pancreas show an interruption of the Wnt-signaling pathway and express gene products of 11q.
Tiemann K; Heitling U; Kosmahl M; Klöppel G
Mod Pathol; 2007 Sep; 20(9):955-60. PubMed ID: 17632456
[TBL] [Abstract][Full Text] [Related]
8. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
9. [The clinical characteristics surgical procedures and prognosis of solid pseudopapillary tumor of the pancreas].
Yang H; Li N; Deng WY; Luo SX
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):211-215. PubMed ID: 28316222
[No Abstract] [Full Text] [Related]
10. [Clinicopathologic features, diagnosis and treatment with solid-pseudopapillary tumor of the pancreas: a report of 33 cases].
Yuan CH; Xiu DR; Shi XY; Ma ZL; Li ZF; Tao M; Jia YM; Xiong JW; Zhang TL
Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):11-4. PubMed ID: 22490282
[TBL] [Abstract][Full Text] [Related]
11. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.
Lu H; Allende D; Liu X; Zhang Y
Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
[TBL] [Abstract][Full Text] [Related]
12. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
13. Solid pseudopapillary tumor of the pancreas: emphasis on differential diagnosis from aggressive tumors of the pancreas.
Aydiner F; Erinanç H; Savaş B; Erden E; Karayalçin K
Turk J Gastroenterol; 2006 Sep; 17(3):219-22. PubMed ID: 16941259
[TBL] [Abstract][Full Text] [Related]
14. The dilemma of "indeterminate" interpretations of pancreatic neuroendocrine tumors on fine needle aspiration.
Ahmed A; VandenBussche CJ; Ali SZ; Olson MT
Diagn Cytopathol; 2016 Jan; 44(1):10-3. PubMed ID: 26402138
[TBL] [Abstract][Full Text] [Related]
15. Solid-papillary tumors of the pancreas: histopathology.
Santini D; Poli F; Lega S
JOP; 2006 Jan; 7(1):131-6. PubMed ID: 16407635
[TBL] [Abstract][Full Text] [Related]
16. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.
Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC
Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515
[TBL] [Abstract][Full Text] [Related]
17. Solid pseudopapillary neoplasm of pancreas: Two case reports.
Gurzu S; Bara T; Sincu M; Gabos S; Vlad DM; Bara T; Beres H; Jung I
Medicine (Baltimore); 2019 Jul; 98(29):e16455. PubMed ID: 31335701
[TBL] [Abstract][Full Text] [Related]
18. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.
Tanigawa M; Nakayama M; Taira T; Hattori S; Mihara Y; Kondo R; Kusano H; Nakamura K; Abe Y; Ishida Y; Okabe Y; Hisaka T; Okuda K; Fujino K; Ito T; Kawahara A; Naito Y; Yamaguchi R; Akiba J; Akagi Y; Yano H
Med Mol Morphol; 2018 Mar; 51(1):32-40. PubMed ID: 28849340
[TBL] [Abstract][Full Text] [Related]
19. Solid pseudopapillary tumor of the pancreas: E-cadherin, β-catenin, CD99 new useful markers with characteristic expression (about two case reports).
Salwa N; Rym D; Raoudha D; Lamia C; Imen A; Maha D; Karima M
Pan Afr Med J; 2021; 40():110. PubMed ID: 34887984
[TBL] [Abstract][Full Text] [Related]
20. [Clear cell papillary renal cell carcinoma: a distinct low-grade renal tumour].
Yang X; Miao N; Gan H; Wang L; Wang C
Zhonghua Bing Li Xue Za Zhi; 2015 Jun; 44(6):372-6. PubMed ID: 26704829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
